HomeProductsBioactive CompoundsMAPK/ERK PathwayJNKCC-930
Chemical structure of CAS 899805-25-5

CC-930

CAS No.899805-25-5
MDL No.MFCD23160040
MFC21H23F3N6O2
MW448.40
InChI KeyIBGLGMOPHJQDJB-MOKVOYLWSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.899805-25-5
Product NameCC-930

Biological Targets

MAPK10·MAPK8·MAPK9

Associated Conditions

discoid lupus erythematosus·idiopathic pulmonary fibrosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

ARC protects cochlear hair cells from neomycin-induced ototoxicity via the Ras/JNK signaling pathway.

Toxicology letters • Vol. 403 • 2025
PMID: 39667535DOI: 10.1016/j.toxlet.2024.12.005

Sub-acute oral exposure to lowest observed adverse effect level of nivalenol exacerbates atopic dermatitis in mice via direct activation of mitogen-activated protein kinase signal in antigen-presenting cells.

Archives of toxicology • Vol. 98, Issue 7 • 2024
PMID: 38616237DOI: 10.1007/s00204-024-03740-3

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.

Clinical and translational medicine • Vol. 5, Issue 1 • 2016
PMID: 27590145PMC: PMC5010551DOI: 10.1186/s40169-016-0117-2

Documentation